서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Publisher

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 81 to 120 of 155

Issue DateTitle / Author(s) / CitationFileAltmetrics
2009-02
Prognostic Implications of and Relationship Between CpG Island Hypermethylation and Repetitive DNA Hypomethylation in Hepatocellular Carcinoma
DOI
2009-02
Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea
DOI
2009-03
4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IκB kinase: Potential role of reactive oxygen species

Park, Sin-Aye; Na, Hye-Kyung; Kim, Eun-Hee; Cha, Young-Nam; Surh, Young-Joon

Cancer Research, Vol.69 No.6, pp.2416-2424

DOI
2009-03
p31(comet) Induces Cellular Senescence through p21 Accumulation and Mad2 Disruption
DOI
2009-04
Association of LETM1 and MRPL36 Contributes to the Regulation of Mitochondrial ATP Production and Necrotic Cell Death
DOI
2009-09
Resveratrol Suppresses Growth of Human Ovarian Cancer Cells in Culture and in a Murine Xenograft Model: Eukaryotic Elongation Factor 1A2 as a Potential Target
DOI
2009-09
Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells
DOI
2009-10
Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: Eukaryotic elongation factor 1A2 as a potential target
DOI
2010-03
An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity
DOI
2010-03
Diallyl Trisulfide Inhibits Phorbol Ester-Induced Tumor Promotion, Activation of AP-1, and Expression of COX-2 in Mouse Skin by Blocking JNK and Akt Signaling

Shrotriya, Sangeeta; Kundu, Joydeb Kumar; Na, Hye-Kyung; Surh, Young-Joon

Cancer Research, Vol.70 No.5, pp.1932-1940

DOI
2010-11
Breaking the NF-kB and STAT3 Alliance Inhibits Inflammation and Pancreatic Tumorigenesis

Surh, Young-Joon; Bode, Ann M.; Dong, Zigang

Cancer Prevention Research, Vol.3 No.11, pp.1379-1381

DOI
2011-03
ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-analysis
DOI
2011-06
Zerumbone Induces Heme Oxygenase-1 Expression in Mouse Skin and Cultured Murine Epidermal Cells through Activation of Nrf2
DOI
2011-07
Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with Sunitinib
DOI
2012-02
Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer
DOI
2012-07
CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis.
DOI
2013-01
STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cells
DOI
2013-01
Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer
DOI
2013-05
Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
DOI
2013-06
RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib
DOI
2013-09
Protein Kinase C-delta-Mediated Recycling of Active KIT in Colon Cancer

Park, Misun; Kim, Won Kyu; Song, Meiying; Park, Minhee; Kim, Hyunki; Nam, Hye Jin; Baek, Sung Hee; Kim, Hoguen

Clinical Cancer Research, Vol.19 No.18, pp. 4961-4971

DOI
2013-09
Protein Kinase C-delta-Mediated Recycling of Active KIT in Colon Cancer

Park, Misun; Kim, Won Kyu; Song, Meiying; Park, Minhee; Kim, Hyunki; Nam, Hye Jin; Baek, Sung Hee; Kim, Hoguen

Clinical Cancer Research, Vol.19 No.18, pp.4961-4971

DOI
2013-12
Esculetin Suppresses Proliferation of Human Colon Cancer Cells by Directly Targeting beta-Catenin
DOI
2014-11
Tumor-derived osteopontin suppresses antitumor immunity by promoting extramedullary myelopoiesis
DOI
2015-05
Molecular changes associated with acquired resistance to crizotinib in ROS1-rearranged non-small cell lung cancer

Song, Ahnah; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Keam, Bhumsuk; Lee, Se-Hoon; Heo, Dae Seog

Clinical Cancer Research, Vol.21 No.10, pp.2379-2387

DOI
2015-06
Optimal patient selection for trastuzumab treatment in HER2-positive advanced gastric cancer
DOI
2016-05
Pan-cancer immunogenomic perspective on the tumor microenvironment based on PD-L1 and CD8 T-cell infiltration
DOI
2016-07
Src as a Therapeutic Target in Biliary Tract Cancer
DOI
2016-10
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity
DOI
2017-01
HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-O13/LOGiC Trial of Lapatinib
DOI
2017-03
Essential role of DNA methyltransferase 1-mediated transcription of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors
DOI
2017-04
AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells
DOI
2017-06
Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition

Jin, Mei Hua; Nam, Ah-Rong; Park, Ji Eun; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn

Molecular Cancer Therapeutics, Vol.16 No.6, pp.1145-1154

DOI
2017-09
Nrf2 Mutagenic Activation Drives Hepatocarcinogenesis

Ngo, Hoang Kieu Chi; Kim, Do-Hee; Cha, Young-Nam; Na, Hye-Kyung; Surh, Young-Joon

Cancer Research, Vol.77 No.18, pp.4797-4808

DOI
2017-10
A first-time-in-human study of GSK2636771, a phosphoinositide 3 kinase beta-selective inhibitor, in patients with advanced solid tumors
DOI
2017-10
Efficacy of sequential ipilimumab monotherapy versus best supportive care for unresectable locally advanced/metastatic gastric or gastroesophageal junction cancer
DOI
2018-06
Safety and antitumor activity of pembrolizumab in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer
DOI
2018-07
Change in topoisomerase 1–positive circulating tumor cells affects overall survival in patients with advanced breast cancer after treatment with etirinotecan pegol
DOI
2018-08
A first-in-human study of the new oral selective estrogen receptor degrader AZD9496 for ER+/HER2- advanced breast cancer
DOI
2018-09
Activation of NKT cells in an anti-PD-1-resistant tumor model enhances antitumor immunity by reinvigorating exhausted CD8 T cells
DOI
1 2 3 4